journal
https://read.qxmd.com/read/36958743/long-covid-clues-about-causes
#1
EDITORIAL
Felicity Liew, Claudia Efstathiou, Peter Jm Openshaw
No abstract text is available yet for this article.
March 23, 2023: European Respiratory Journal
https://read.qxmd.com/read/36958742/cardiopulmonary-exercise-testing-in-the-follow-up-after-acute-pulmonary-embolism
#2
JOURNAL ARTICLE
Ioannis T Farmakis, Luca Valerio, Stefano Barco, Eva Alsheimer, Ralf Ewert, George Giannakoulas, Lukas Hobohm, Karsten Keller, Anna C Mavromanoli, Stephan Rosenkranz, Timothy A Morris, Stavros V Konstantinides, Matthias Held, Daniel Dumitrescu
BACKGROUND: Cardiopulmonary exercise testing (CPET) may provide prognostically valuable information during follow-up after pulmonary embolism (PE). OBJECTIVE: To investigate the association of patterns and degree of exercise limitation, as assessed by CPET, with clinical, echocardiographic, laboratory abnormalities and quality of life (QoL) after PE. METHODS: In a prospective cohort study of unselected consecutive all-comers with PE, survivors of the index acute event underwent 3-month and 12-month follow-up, including CPET...
March 23, 2023: European Respiratory Journal
https://read.qxmd.com/read/36958741/air-pollution-and-copd-gold-2023-committee-report
#3
JOURNAL ARTICLE
Don D Sin, Dany Doiron, Alvar Agusti, Antonio Anzueto, Peter J Barnes, Bartolome R Celli, Gerard J Criner, David Halpin, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca, Alberto Papi, Ian Pavord, Nicolas Roche, Dave Singh, Robert Stockley, M Victorina Lopez Varlera, Jadwiga Wedzicha, Claus Volgelmeier, Jean Bourbeau
Exposure to air pollution is a major contributor to the pathogenesis of chronic obstructive pulmonary disease (COPD) worldwide. Indeed, most recent estimates suggest that 50% of the total attributable risk of COPD may be related to air pollution. In response, the GOLD Scientific Committee performed a comprehensive review on this topic, qualitatively synthesized the evidence to date and proffered recommendations to mitigate the risk.The review found that both gaseous and particulate components of air pollution are likely contributors to COPD...
March 23, 2023: European Respiratory Journal
https://read.qxmd.com/read/36922030/monocyte-migration-profiles-define-disease-severity-in-acute-covid-19-and-unique-features-of-long-covid
#4
JOURNAL ARTICLE
Nicholas A Scott, Laurence Pearmain, Sean B Knight, Oliver Brand, David J Morgan, Christopher Jagger, Sarah Harbach, Saba Khan, Halima A Shuwa, Miriam Franklin, Verena Kästele, Thomas Williams, Ian Prise, Flora A McClure, Pamela Hackney, Lara Smith, Madhvi Menon, Joanne E Konkel, Criag Lawless, James Wilson, Aleaxander G Mathioudakis, Stefan C Stanel, Andrew Ustianowski, Gabriella Lindergard, Seema Brij, Nawar Diar Bakerly, Paul Dark, Christopher Brightling, Pilar Rivera-Ortega, Graham M Lord, Alex Horsley, Karen Piper Hanley, Timothy Felton, Angela Simpson, John R Grainger, Tracy Hussell, Elizabeth R Mann
BACKGROUND: COVID-19 is associated with a dysregulated immune response but it is unclear how immune dysfunction contributes to the chronic morbidity persisting in many COVID-19 patients during convalescence (long COVID). METHODS: We assessed phenotypical and functional changes of monocytes in COVID-19 patients during hospitalization and up to 9 months of convalescence following COVID-19, respiratory syncytial virus (RSV) or influenza A (flu). Progressive fibrosing interstitial lung disease (PFILD) patients were included a positive control for severe, ongoing lung injury...
March 15, 2023: European Respiratory Journal
https://read.qxmd.com/read/36858445/eligibility-criteria-from-pharmaceutical-randomised-controlled-trials-of-idiopathic-pulmonary-fibrosis-a-registry-based-study
#5
JOURNAL ARTICLE
Yet H Khor, Max Schulte, Kerri A Johannson, Veronica Marcoux, Jolene H Fisher, Deborah Assayag, Helene Manganas, Nasreen Khalil, Martin Kolb, Christopher J Ryerson
BACKGROUND: Little is known about generalisability of randomised controlled trials (RCTs) for idiopathic pulmonary fibrosis (IPF). We evaluated eligibility criteria for phase III IPF RCTs to determine their representativeness in clinical registries, and calculated forced vital capacity (FVC) changes according to eligibility criteria. METHODS: Common eligibility criteria used in >60% of IPF RCTs were identified from a literature search and applied to patients with IPF from prospective Australian and Canadian registries...
March 1, 2023: European Respiratory Journal
https://read.qxmd.com/read/36858444/a-patient-tailored-approach-for-corticosteroid-treatment-in-covid-19-still-not-there-yet
#6
EDITORIAL
Mattia Nigro, James D Chalmers, Stefano Aliberti
No abstract text is available yet for this article.
March 1, 2023: European Respiratory Journal
https://read.qxmd.com/read/36858443/global-initiative-for-chronic-obstructive-lung-disease-2023-report-gold-executive-summary
#7
JOURNAL ARTICLE
Alvar Agustí, Bartolome R Celli, Gerard J Criner, David Halpin, Antonio Anzueto, Peter Barnes, Jean Bourbeau, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca, Kevin Mortimer, Alberto Papi, Ian Pavord, Nicolas Roche, Sundeep Salvi, Don D Sin, Dave Singh, Robert Stockley, M Victorina López Varela, Jadwiga A Wedzicha, Claus F Vogelmeier
No abstract text is available yet for this article.
March 1, 2023: European Respiratory Journal
https://read.qxmd.com/read/36858442/implications-of-the-new-ers-ats-standard-on-the-interpretation-of-lung-function-tests
#8
LETTER
Paul Desbordes, Maarten De Vos, Julie Maes, Frans de Jongh, Karl Sylvester, Claus Franz Vogelmeier, Anh Tuan Dinh-Xuan, Jann Mortensen, Wim Janssens, Marko Topalovic
No abstract text is available yet for this article.
March 1, 2023: European Respiratory Journal
https://read.qxmd.com/read/36822634/inhaled-anti-tslp-antibody-fragment-ecleralimab-blocks-responses-to-allergen-in-mild-asthma
#9
JOURNAL ARTICLE
Gail M Gauvreau, Jens M Hohlfeld, Mark J FitzGerald, Louis-Philippe Boulet, Donald W Cockcroft, Beth E Davis, Stephanie Korn, Oliver Kornmann, Richard Leigh, Irvin Mayers, Henrik Watz, Sarah S Grant, Monish Jain, Maciej Cabanseki, Peter E Pertel, Ieuan Jones, Jean R Lecot, Hui Cao, Paul M O'Byrne
RATIONALE: Thymic stromal lymphopoietin (TSLP) is a key upstream regulator driving allergic inflammatory responses. OBJECTIVE: We evaluated efficacy and safety of ecleralimab, a potent inhaled neutralizing antibody fragment against human TSLP, using allergen inhalation challenge (AIC) in subjects with mild atopic asthma. METHODS: This was a 12-week, randomised, double-blind, placebo-controlled, parallel-design, multicentre allergen bronchoprovocation study conducted at 10 centres across Canada and Germany...
February 23, 2023: European Respiratory Journal
https://read.qxmd.com/read/36822633/a-predictive-model-for-acute-exacerbation-of-idiopathic-interstitial-pneumonias
#10
JOURNAL ARTICLE
Masato Karayama, Yoichiro Aoshima, Takahito Suzuki, Kazutaka Mori, Nobuko Yoshizawa, Shintaro Ichikawa, Shinpei Kato, Koshi Yokomura, Masato Kono, Dai Hashimoto, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Satoshi Goshima, Naoki Inui, Takafumi Suda
BACKGROUND: Acute exacerbation of idiopathic interstitial pneumonias (AE-IIPs) induces permanent pulmonary dysfunction and is potentially lethal. The unpredictable occurrence of AE-IIPs remains an important clinical issue in the management of IIPs. METHODS: In this multicentre, retrospective, observational study, a predictive score for AE-IIPs was designed using clinical factors based on multivariate Fine-Gray analysis in patients with IIPs. RESULTS: Based on multivariate Fine-Gray analysis in an exploratory cohort of 487 patients with IIPs, the predictive score for AE-IIPs was determined as follows: 1 point each was added for honeycombing on high-resolution computed tomography (H), age >75 years (A), and lactate dehydrogenase level >222 U/L (L); the total score ranged from 0 to 3 (HAL score)...
February 23, 2023: European Respiratory Journal
https://read.qxmd.com/read/36822632/nasal-nitric-oxide-measurement-in-children-for-the-diagnosis-of-primary-ciliary-dyskinesia-european-respiratory-society-technical-standard
#11
JOURNAL ARTICLE
Nicole Beydon, Panayotis Kouis, June K Marthin, Philipp Latzin, Murielle Colas, Stephanie D Davis, Eric Haarman, Amanda Lea Harris, Claire Hogg, Emma Kilbride, Claudia E Kuehni, Diana Marangu, Kim G Nielsen, Catherine Pendergrast, Phil Robinson, Nisreen Rumman, Matthew Rutter, Woolf T Walker, Thomas Ferkol, Jane S Lucas
Nasal nitric oxide (nNO) is extremely low in most people with primary ciliary dyskinesia (PCD) and its measurement is an important contributor to making the diagnosis. Existing guidelines and technical standards focus on nNO measurements in older, cooperative children using chemiluminescent analysers. However, measurements of nNO in pre-school children (2-5 years) may facilitate early diagnosis, and electrochemical rather than chemiluminescence analysers are widely used. Pre-schoolers often need different methods to be employed when measuring nNO...
February 23, 2023: European Respiratory Journal
https://read.qxmd.com/read/36822631/associations-of-improved-air-quality-with-lung-function-growth-from-childhood-to-adulthood-the-bamse-study
#12
JOURNAL ARTICLE
Zhebin Yu, Simon Kebede Merid, Tom Bellander, Anna Bergström, Kristina Eneroth, Antonios Georgelis, Jenny Hallberg, Inger Kull, Petter Ljungman, Susanna Klevebro, Massimo Stafoggia, Gang Wang, Göran Pershagen, Olena Gruzieva, Erik Melén
BACKGROUND: The beneficial effect of improving air quality on lung function development remains understudied. We assessed associations of changes in ambient air pollution levels with lung function growth from childhood until young adulthood in a Swedish cohort study. METHODS: In the prospective birth cohort BAMSE (Children, Allergy, Environment, Stockholm, Epidemiology), spirometry was conducted at the 8-year (2002-2004), 16-year (2011-2013) and 24-year follow-ups (2016-2019)...
February 23, 2023: European Respiratory Journal
https://read.qxmd.com/read/36796836/the-french-compassionate-program-of-elexacaftor-tezacaftor-ivacaftor-in-people-with-cystic-fibrosis-with-advanced-lung-disease-and-no-f508del-cftr-variant
#13
JOURNAL ARTICLE
Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, Isabelle Durieu, Reem Kanaan, Julie Macey, Dominique Grenet, Michele Porzio, Nathalie Coolen-Allou, Raphael Chiron, Christophe Marguet, Benoit Douvry, Nadine Dufeu, Isabelle Danner-Boucher, Pierre Foucaud, Lydie Lemonnier, Emmanuelle Girodon, Jennifer Da Silva, Clémence Martin
BACKGROUND: The European Medicines Agency has approved the cystic fibrosis transmembrane conductance regulator (CFTR) modulator combination elexacaftor-tezacaftor-ivacaftor (ETI) for people with cystic fibrosis (pwCF) carrying at least one F508del variant. The United States Food and Drug Administration (FDA) also approved ETI for pwCF carrying one of 177 rare variants. METHODS: An observational study was conducted to evaluate the effectiveness of ETI in pwCF with advanced lung disease that were not eligible to ETI in Europe...
February 16, 2023: European Respiratory Journal
https://read.qxmd.com/read/36796835/definitions-and-diagnosis-of-copd-state-of-the-art
#14
JOURNAL ARTICLE
Sachin Ananth, John R Hurst
No abstract text is available yet for this article.
February 16, 2023: European Respiratory Journal
https://read.qxmd.com/read/36796834/obstructive-sleep-apnoea-and-5-year-cognitive-decline-in-the-elderly
#15
JOURNAL ARTICLE
Nicola Andrea Marchi, Geoffroy Solelhac, Mathieu Berger, José Haba-Rubio, Nadia Gosselin, Peter Vollenweider, Pedro Marques-Vidal, Julius Popp, Armin von Gunten, Martin Preisig, Bogdan Draganski, Raphael Heinzer
BACKGROUND: The relationship between obstructive sleep apnoea (OSA) and cognitive decline remains controversial, especially in the elderly population. We used data from the HypnoLaus study to assess associations between OSA and longitudinal cognitive changes in a sample of community-dwelling elderly individuals. METHODS: We studied associations between polysomnographic OSA parameters (of breathing/hypoxaemia and sleep fragmentation) and cognitive changes over a 5-year period, after adjustment for potential confounders...
February 16, 2023: European Respiratory Journal
https://read.qxmd.com/read/36796833/lung-volume-reduction-surgery-versus-endobronchial-valves-a-randomised-controlled-trial
#16
JOURNAL ARTICLE
Sara C Buttery, Winston Banya, Rocco Bilancia, Elizabeth Boyd, Julie Buckley, Neil J Greening, Kay Housely, Simon Jordan, Samuel V Kemp, Alan J B Kirk, Lorna Latimer, Kelvin Lau, Rod Lawson, Adam Lewis, John Moxham, Sridhar Rathinam, Michael C Steiner, Sara Tenconi, David Waller, Pallav L Shah, Nicholas S Hopkinson
BACKGROUND: Lung volume reduction surgery (LVRS) and bronchoscopic lung volume reduction (BLVR) with endobronchial valves (EBVs) can improve outcomes in appropriately selected patients with emphysema. However, no direct comparison data exist to inform clinical decision-making in people who appear suitable for both procedures. Our aim was to investigate whether LVRS produces superior health outcomes when compared to BLVR at 12 months. METHODS: this multi-centre, single-blind parallel-group trial randomised patients from five UK hospitals, who were suitable for a targeted lung volume reduction procedure, to either LVRS or BLVR, and compared outcomes at 1 year using the i-BODE score...
February 16, 2023: European Respiratory Journal
https://read.qxmd.com/read/36758986/regulating-the-cell-shift-of-endothelial-cell-like-myofibroblasts-in-pulmonary-fibrosis
#17
JOURNAL ARTICLE
Xiuju Wu, Daoqin Zhang, Xiaojing Qiao, Li Zhang, Xinjiang Cai, Jaden Ji, Jocelyn A Ma, Yan Zhao, John A Belperio, Kristina I Boström, Yucheng Yao
Pulmonary fibrosis is a common and severe fibrotic lung disease with high morbidity and mortality. Recent studies have reported a large number of unwanted myofibroblasts appearing in pulmonary fibrosis, and shown that the sustained activation of myofibroblasts is essential for unremitting interstitial fibrogenesis. However, the origin of these myofibroblasts remains poorly understood. Here, we create new mouse models of pulmonary fibrosis and identify a previously unknown population of endothelial cell (EC)-like myofibroblasts in normal lung tissue...
February 9, 2023: European Respiratory Journal
https://read.qxmd.com/read/36758985/minimal-clinically-important-difference-for-impulse-oscillometry-in-adults-with-asthma
#18
JOURNAL ARTICLE
Mustafa Abdo, Anne-Marie Kirsten, Erika von Mutius, Matthias Kopp, Gesine Hansen, Klaus F Rabe, Henrik Watz, Frederik Trinkmann, Thomas Bahmer
BACKGROUND: Impulse oscillometry (IOS) allows an effort-independent evaluation of small airway function in asthma. Unfortunately, well-determined minimal clinically important differences (MCID) for IOS-measures are lacking. Here, we provide MCIDs for frequently used IOS-measures, namely frequency dependence of resistance (FDR) and area of reactance (AX) in patients with asthma. METHODS: We performed IOS at baseline and 1 year later in adult patients with mild to severe asthma ( n =235) ...
February 9, 2023: European Respiratory Journal
https://read.qxmd.com/read/36702498/idiopathic-pulmonary-fibrosis-state-of-the-art-for-2023
#19
JOURNAL ARTICLE
Anna J Podolanczuk, Carey C Thomson, Martine Remy-Jardin, Luca Richeldi, Fernando J Martinez, Martin Kolb, Ganesh Raghu
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterized by worsening respiratory symptoms and physiologic impairment. Increasing awareness of the clinical manifestations of IPF, more widespread use of computed tomography scans, and other potential factors have contributed to a rising prevalence of IPF over the last two decades, especially among people over the age of 65. Significant advances in the understanding of the pathobiology of IPF have emerged, and multiple genetic and nongenetic contributors have been identified...
January 26, 2023: European Respiratory Journal
https://read.qxmd.com/read/36669778/the-impact-of-depression-and-anxiety-on-the-risk-of-exacerbation-in-adults-with-bronchiectasis-a-prospective-cohort-study
#20
LETTER
Yong-Hua Gao, Hui-Zhen Zheng, Hai-Wen Lu, Yuan-Yuan Li, Yun Feng, Bei Mao, Jiu-Wu Bai, Shuo Liang, Ke-Bin Cheng, Shu-Yi Gu, Xiao-Li Sun, Jian-Xiong Li, Ai Ge, Man-Hui Li, Jia-Wei Yang, Lu Bai, Han-Yu Yu, Jie-Ming Qu, Jin-Fu Xu
No abstract text is available yet for this article.
January 20, 2023: European Respiratory Journal
journal
journal
20109
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.